Evidence map›Paper›PMID 41198616›Full record

ArticleNature communications2025

Salmonella multimutants enable efficient identification of SPI-2 effector protein function in gut inflammation and systemic colonization.

Joshua P M Newson, Flavia Gürtler, Pietro Piffaretti, Nicolò Barbieri, Annina Meyer, Anna Sintsova, Manja Barthel, Yves Steiger, Sarah C McHugh, Ursina Enz and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Infection strategies ofGut microbes reports · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

  • Update of
    2024
5 · Who and what money

Authors and funding

13 authors.

Joshua P M NewsonInstitute of Microbiology, ETH Zurich, Zurich, Switzerland. newsonj@ethz.ch.ORCID http://orcid.org/0000-0003-2091-7943
Flavia GürtlerInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Pietro PiffarettiInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Nicolò BarbieriInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Annina MeyerInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0009-0006-3110-6598
Anna SintsovaInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Manja BarthelInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Yves SteigerInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-8048-250X
Sarah C McHughInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.
Ursina EnzInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-4220-2650
Neal M AltoDepartment of Microbiology, University of Texas (UT) Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-7602-3853
Shinichi SunagawaInstitute of Microbiology, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-3065-0314
Wolf-Dietrich HardtInstitute of Microbiology, ETH Zurich, Zurich, Switzerland. hardt@micro.biol.ethz.ch.ORCID http://orcid.org/0000-0002-9892-6420

Funding

Type III effector regulation of host signal transduction systemsR01AI083359 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI ALTO, NEAL MATHEW · 2009 to 2024
$6.3M
Type III effector regulation of host GTPase signalingR56AI083359 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI ALTO, NEAL MATHEW · 2014 to 2014
$452k
NIAID NIH HHS R01 AI083359NIAID NIH HHS R56 AI083359Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 10.001.588Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 310030_192567Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 51NF40_180575
6 · The paper itself

Abstract

Salmonella enterica relies on translocation of effector proteins through the SPI-2 type III secretion system (T3SS) for pathogenesis. More than 30 effectors contribute to manipulation of host cells through diverse mechanisms, but interdependency or redundancy between effectors complicates the discovery of effector phenotypes using single mutant strains. Here, we engineer six mutant strains to be deficient in groups of SPI-2 effectors, as defined by their reported function. Using various animal models of infection, we show that three main phenotypes define the functional contribution of the SPI-2 T3SS to infection. Multimutant strains deficient for intracellular replication, for manipulation of host cell defences, or for expression of virulence plasmid effectors all show strong attenuation in vivo, while mutants representing approximately half of the known effector complement show phenotypes similar to the wild-type parent strain. By additionally removing the SPI-1 T3SS, we find groups of effectors that contribute to SPI-2 T3SS-driven enhancement of gut inflammation. Further, we provide an example of how iterative mutation can be used to find a minimal number of effector deletions required for attenuation, and thus establish that the SPI-2 effectors SopD2 and GtgE are crucial for promotion of gut inflammation and mucosal pathology.

Indexed as

Bacterial ProteinsSalmonella InfectionsSalmonella typhimuriumType III Secretion SystemsAnimalsFemaleHumansInflammationMembrane ProteinsMiceMice, Inbred C57BLMutationVirulenceBacterial ProteinsMembrane ProteinsSPI-2 protein, SalmonellaType III Secretion Systems

Identifiers

PMID41198616
PMCPMC12592711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.